Clinical Trials

April 16, 2025

Understanding how ROR1-targeted therapies work—and whether they apply to your specific blood cancer type—can help you make more informed treatment decisions.

March 28, 2025

In this article, discover how loncastuximab with rituximab shows promise for relapsed/refractory high-risk follicular lymphoma in a phase 2 clinical trial.

December 03, 2024

Read the latest findings from Dr. Baron and her team at Huntsman Cancer Institute on the efficacy of BR versus R-CHOP in treating follicular lymphoma.

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

July 22, 2024

Learn about bendamustine, a treatment option for follicular lymphoma. Discover how it works, potential side effects, and important safety considerations.

October 10, 2023

A non-chemo treatment combination of zanubrutinib and obinutuzumab evaluated in the ROSEWOOD study showed promising treatment results.